NovoCure (NVCR) FCF Margin Growth (3y) (2017 - 2026)
NovoCure (NVCR) FCF Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 60.00 |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | 2,420.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,420.00 |
| Mar 31, 2026 | 795.00 |
| Dec 31, 2025 | -524.00 |
| Sep 30, 2025 | -384.00 |
| Jun 30, 2025 | -2,175.00 |
| Mar 31, 2025 | -2,347.00 |
| Dec 31, 2024 | -778.00 |
| Sep 30, 2024 | -1,599.00 |
| Jun 30, 2024 | -2,640.00 |
| Mar 31, 2024 | -4,155.00 |
| Dec 31, 2023 | -4,913.00 |
| Sep 30, 2023 | -4,031.00 |
| Jun 30, 2023 | -3,167.00 |
| Mar 31, 2023 | -1,754.00 |
| Dec 31, 2022 | -1,183.00 |
| Sep 30, 2022 | -49.00 |
| Jun 30, 2022 | 57.00 |
| Mar 31, 2022 | 267.00 |
| Dec 31, 2021 | -2,146.00 |
| Sep 30, 2021 | 918.00 |